Advisory Commission on Childhood Vaccines; Notice of Meeting, 14311 [2013-04953]

Download as PDF Federal Register / Vol. 78, No. 43 / Tuesday, March 5, 2013 / Notices 1. McEntire, Jennifer and Bhatt, Tejas, ‘‘Pilot Projects for Improving Product Tracing Along the Food Supply System—Final Report,’’ Institute of Food Technologists, August 2012. Dated: February 27, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013–04997 Filed 3–4–13; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration emcdonald on DSK67QTVN1PROD with NOTICES Advisory Commission on Childhood Vaccines; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: March 07, 2013, 10:00 a.m. to 4:00 p.m. EDT. Place: Audio Conference Call. The ACCV will meet on Thursday, March 7, from 10:00 a.m. to 4:00 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1– 800–369–3104 on March 7 and providing the following information: Leader’s Name: Dr. Vito Caserta. Password: ACCV. Agenda: The agenda items for the March meeting will include, but are not limited to: Updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http:// www.hrsa.gov/vaccinecompensation/ accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate. Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857 or email: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or VerDate Mar<15>2010 15:14 Mar 04, 2013 Jkt 229001 professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by email, mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For Further Information Contact: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–6593 or email: aherzog@hrsa.gov. Dated: February 26, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–04953 Filed 3–4–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority This notice amends Part R of the Statement of Organization, Functions and Delegations of Authority of the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 78 FR 956–957, dated January 7, 2013). This notice reflects organizational changes to the Health Resources and Services Administration. This notice updates the functional statement for the Office of Federal Assistance Management (RJ). Specifically, this notice: (1) Moves the grant officer and loan officer function from the Office of the Associate Administrator (RJ) to the Division of Grants Management Operations (RJ3); and (2) moves the electronic grant management system function from the Division of Grants Management Operations (RJ3) to the Office of the Associate Administrator (RJ). PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 14311 Chapter RJ—Office of Federal Assistance Management Section RJ–20, Functions (1) Delete the functional statement for the Office of the Associate Administrator (RJ) and the functional statement for the Division of Grants Management Operations (RJ3), and replace in their entirety. Office of Federal Assistance Management (RJ) Provides national leadership in the administration and assurance of the financial integrity of HRSA’s programs and provides oversight over all HRSA activities to ensure that HRSA’s resources are being properly used and protected. Provides leadership, direction, and coordination to all phases of grants policy, administration, and independent review of competitive grant applications. Specifically: (1) Serves as the Administrator’s principal source for grants policy and financial integrity of HRSA programs; (2) exercises oversight over the Agency’s business processes related to assistance programs; (3) facilitates, plans, directs, and coordinates the administration of HRSA grant policies and operations; (4) directs and carries out the independent review of grant applications for all of HRSA’s programs; (5) exercises the sole responsibility within HRSA for all aspects of grant and cooperative agreement receipt, award, and postaward processes: and (6) provides oversight of the management and maintenance of, and enhancements to, the electronic grant management system that enables staff to perform their dayto-day work. Division of Grants Management Operations (RJ3) (1) Plans, directs and carries out the grants officer functions for all of HRSA’s grant programs as well as awarding official functions for various scholarship, loan, and loan repayment assistance programs; (2) participates in the planning, development, and implementation of policies and procedures for grants and cooperative agreements; (3) provides assistance and technical consultation to program offices and grantees in the application of laws, regulations, policies, and guidelines relative to the Agency’s grant and cooperative agreement programs; (4) develops standard operating procedures, methods, and materials for the administration of the Agency’s grants programs; (5) establishes standards and guides for grants management operations; (6) reviews grantee financial status reports and prepares reports and E:\FR\FM\05MRN1.SGM 05MRN1

Agencies

[Federal Register Volume 78, Number 43 (Tuesday, March 5, 2013)]
[Notices]
[Page 14311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04953]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: March 07, 2013, 10:00 a.m. to 4:00 p.m. EDT.
    Place: Audio Conference Call.
    The ACCV will meet on Thursday, March 7, from 10:00 a.m. to 4:00 
p.m. (EDT). The public can join the meeting via audio conference call 
by dialing 1-800-369-3104 on March 7 and providing the following 
information:
    Leader's Name: Dr. Vito Caserta.
    Password: ACCV.
    Agenda: The agenda items for the March meeting will include, but 
are not limited to: Updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice (DOJ), National Vaccine 
Program Office (NVPO), Immunization Safety Office (Centers for Disease 
Control and Prevention), National Institute of Allergy and Infectious 
Diseases (National Institutes of Health) and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). A draft agenda 
and additional meeting materials will be posted on the ACCV Web site 
(http://www.hrsa.gov/vaccinecompensation/accv.htm) prior to the 
meeting. Agenda items are subject to change as priorities dictate.
    Public Comment: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 11C-
26, 5600 Fishers Lane, Rockville, MD 20857 or email: aherzog@hrsa.gov. 
Requests should contain the name, address, telephone number, email 
address, and any business or professional affiliation of the person 
desiring to make an oral presentation. Groups having similar interests 
are requested to combine their comments and present them through a 
single representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. DVIC will notify each 
presenter by email, mail or telephone of their assigned presentation 
time. Persons who do not file an advance request for a presentation, 
but desire to make an oral statement, may announce it at the time of 
the public comment period. Public participation and ability to comment 
will be limited to space and time as it permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 
11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-
6593 or email: aherzog@hrsa.gov.

    Dated: February 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-04953 Filed 3-4-13; 8:45 am]
BILLING CODE 4165-15-P